Stocks · Healthcare · Biotechnology
Vericel Corporation VCEL
$40.15 +1.80% Close, Oct 2, 2026 · NASDAQ · Market cap $2.06B
High qualityLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.47, up 287.9% year over year.
- The shares trade at 85.8× trailing earnings, lower than 90% of the company's own readings over the past five years.
- Revenue over the last four quarters was $306.3M, up 23.0% from a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 30%
- EPS growth (TTM, YoY)Top 6%
- FCF growth (TTM, YoY)Bottom 24%
- Revenue growth, 3-year CAGRTop 32%
- Revenue growth accelerationTop 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 26%
- Gross marginTop 37%
- Operating marginTop 33%
- Cash conversion (OCF / net income)Top 22%
- Accruals (lower is better)Top 38%
- Net debt / EBITDA (lower is better)Top 21%
- Interest coverTop 7%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 27%
- Free-cash-flow yieldTop 28%
- EBITDA / enterprise valueTop 32%
- Sales / enterprise valueBottom 40%
- P/E vs own 5-year history (lower is better)Top 25%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 43%
- 6-month returnTop 41%
- 1-year return vs S&P 500Top 36%
- Distance from 52-week highTop 29%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 30%
- Upside to consensus price targetBottom 45%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 8%
- Maximum drawdown, 3 yearsTop 26%
- Beta vs S&P 500 (lower is better)Top 31%
- Net debt / EBITDA (lower is better)Top 21%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 22.4% | 23.0% | ↑ |
| EPS growth (YoY) | 1077.4% | 287.9% | ↓ |
| Gross margin | 73.5% | 74.6% | ↑ |
| Operating margin | 0.5% | 6.0% | ↑ |
| FCF margin | 25.8% | 16.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 23.0% | 22.4% | ↑ | Top 30% |
| EPS growth (TTM, YoY) | 287.9% | 1077.4% | ↓ | Top 6% |
| Gross margin | 74.6% | 73.5% | ↑ | Top 37% |
| Operating margin | 6.0% | 0.5% | ↑ | Top 33% |
| Net margin | 7.9% | 2.9% | ↑ | — |
| Free-cash-flow margin | 16.2% | 25.8% | ↓ | — |
| Return on invested capital | 3.8% | — | Top 26% | |
| Revenue growth, 3-year CAGR | 18.9% | — | Top 32% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.88×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 5.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.85×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 28.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.13%
- Shareholder yield
- -0.13%
- Share count change, 1 year
- +1.1%
- Share count change, 3-year CAGR
- +2.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- -1.1%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $61.33
- Target vs current price
- +52.8%
- Analysts with a rating
- 14
- Share rating Buy or Strong Buy
- 64%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +238.2% | +2.1% | -2.7% | -9.0% | — |
| May 7, 2026 | +20.0% | -4.5% | -10.7% | -3.0% | +25.2% |
| Feb 26, 2026 | +0.0% | +1.6% | -5.7% | -15.2% | -5.2% |
| Nov 6, 2025 | +600.0% | +4.2% | +8.7% | -1.1% | -0.3% |
| Jul 31, 2025 | +75.0% | -14.1% | -10.7% | -11.7% | -11.5% |
| May 8, 2025 | -155.6% | +3.5% | +4.5% | +7.2% | -7.1% |
| Feb 27, 2025 | +22.6% | -6.1% | -2.5% | -12.2% | -21.7% |
| Nov 7, 2024 | +60.0% | +4.1% | +15.5% | +17.7% | +28.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $0.04 | -$0.03 | +238.2% | $77.5M |
| May 7, 2026 | -$0.12 | -$0.15 | +20.0% | $68.4M |
| Feb 26, 2026 | $0.45 | $0.45 | +0.0% | $92.9M |
| Nov 6, 2025 | $0.10 | -$0.02 | +600.0% | $67.5M |
| Jul 31, 2025 | -$0.01 | -$0.04 | +75.0% | $63.2M |
| May 8, 2025 | -$0.23 | -$0.09 | -155.6% | $52.6M |
| Feb 27, 2025 | $0.38 | $0.31 | +22.6% | $75.4M |
| Nov 7, 2024 | -$0.02 | -$0.05 | +60.0% | $57.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 85.8× | 273.0× | 10th | Top 27% |
| P/E (forward) | 75.1× | — | — | — |
| EV / EBITDA | 52.6× | — | — | Top 32% |
| EV / Sales | 6.60× | — | — | Bottom 40% |
| Free-cash-flow yield | 2.41% | — | — | Top 28% |
| Earnings yield | 1.17% | — | — | Top 27% |
P/E over the past five years
Range 84.3× – 289.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +29.9%
- Earnings per share growth (TTM)
- +287.9%
- Change in P/E multiple
- -64.9%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 16
- 50-day average slope (20 days)
- -5.8%
- 200-day average slope (20 days)
- +0.3%
- Distance from 50-day average
- -4.7%
- Distance from 200-day average
- +4.9%
- RSI (14)
- 48.2
- Relative volume
- 0.96×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 28.8%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.78
- Correlation with S&P 500
- 0.29
- Current drawdown from 1-year high
- -16.9%
- Maximum drawdown, 3 years
- -52.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 28, 2021 | Nov 9, 2022 | -74.0% | 346 days | Not yet recovered |
| Apr 26, 2021 | May 12, 2021 | -26.3% | 12 days | 29 days (Jun 23, 2021) |
| Feb 19, 2021 | Mar 4, 2021 | -21.4% | 9 days | 10 days (Mar 18, 2021) |
| Oct 9, 2020 | Oct 30, 2020 | -15.1% | 15 days | 5 days (Nov 6, 2020) |
| Mar 19, 2021 | Mar 29, 2021 | -14.2% | 6 days | 7 days (Apr 8, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.06B
- P/E (TTM)
- 85.8
- EPS, diluted (TTM)
- $0.47
- Revenue (TTM)
- $306.3M
- 52-week range
- $28.95 – $49.32
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $156.2M | $164.4M | $197.5M | $237.2M | $276.3M |
| Gross profit | $106.0M | $109.8M | $135.6M | $172.1M | $205.6M |
| Operating income | -$7.9M | -$17.1M | -$6.5M | $4.5M | $11.0M |
| Net income | -$7.5M | -$16.7M | -$3.2M | $10.4M | $16.5M |
| EPS (diluted) | -$0.16 | -$0.35 | -$0.07 | $0.20 | $0.32 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $57.9M | $75.4M | $52.6M | $63.2M | $67.5M | $92.9M | $68.4M | $77.5M |
| Net income | -$901,000 | $19.8M | -$11.2M | -$553,000 | $5.1M | $23.2M | -$6.3M | $2.2M |
| EPS (diluted) | -$0.02 | $0.38 | -$0.23 | -$0.01 | $0.10 | $0.45 | -$0.12 | $0.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $29.0M | $17.7M | $35.3M | $58.2M | $51.9M |
| Capital expenditure | -$7.9M | -$7.6M | -$27.5M | -$64.0M | -$27.2M |
| Free cash flow | $21.1M | $10.1M | $7.8M | -$5.8M | $24.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $11.2M | $3.7M | $6.0M | $24.5M | $13.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $162.5M
- Total assets
- $502.9M
- Total liabilities
- $132.8M
- Total debt
- $92.5M
- Net debt
- -$32.8M
- Shareholders’ equity
- $370.0M
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 5,483,102
- Days to cover
- 12.13
- Change vs previous report
- +15.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 16, 2013
- 1-for-20
- Feb 18, 2010
- 1-for-8